Major Pharmaceuticals has recalled 224 cartons of Tolterodine Tartrate Extended-Release Capsules (2 mg), a prescription medication used to treat overactive bladder. The recall was initiated because routine stability testing showed the capsules did not meet the required specifications for how the drug dissolves in the body. This issue could potentially affect how the medication is released and absorbed in your system.
If the medication does not dissolve at the specified rate, it may not work effectively to treat symptoms. To date, there have been no reported injuries or adverse events related to this recall.
You have 2 options:
Recall #: D-0304-2025; Distributed by Major Pharmaceuticals
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.